Insulin therapy in type 2 diabetes is no longer a secondary care activity in the Netherlands

References 

1. Rutten GEHM, De Grauw WJC, Nijpels G, Goudswaard AN, Uitewaal PJM, Van der Does FEE, et al. Guideline on diabetes care of the Dutch college of GPs (NHG Standaard Diabetes Mellitus type 2). Huisarts en Wetenschap. 2006;49:137–152
2. Goyder EC, McNally PG, Drucquer M, Spiers N, Botha JL. Shifting of care for diabetes from secondary to primary care, 1990–5: review of general practices. BMJ. 1998;316:1505–1506
   • MEDLINE
   • CrossRef
3. Khunti K, Ganguli S. Who looks after people with diabetes: primary or secondary care?. J. R. Soc. Med. 2000;93:183–186
   • MEDLINE
4. Brunton S, Carmichael B, Funnel M, Lorber D, Rakel R, Rubin R. The role of insulin. Type 2 diabetes. Fam. Pract. Suppl. 2005;445–452
5. Van Avendonk M, Gorter K, Van den Donk M, Rutten GE. Niet alle huisartsen hebben de praktijkorganisatie om optimale diabeteszorg te leveren. Een vragenlijstonderzoek. (Not all general practitioners have the practice organisation to provide optimal diabetes care. A questionnaire survey). Huisarts en Wetenschap. 2007;50:529–534
6. Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients’ fears and hopes about insulin therapy—the basis of patient reluctance. Diabetes Care. 1997;20:292–298
   • MEDLINE
7. Snoek F. Breaking the barriers to optimal glycaemic control-what physicians need to know from patients’ perspectives. Int. J. Clin. Pract. Suppl. 2002;129:80–84
8. Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int. J. Obesity. 2002;26(Suppl. 3):s18–s24
9. M. Peyrot, R.R. Rubin, T. Lauritzen, S.E. Skovlund, F.J. Snoek, D.R. Matthews, R. Landgraf, L. Kleinebreil, on behalf of the International DAWN Advisory Panel, Resistance to Insulin Therapy Among Patients and Providers: Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study, Diabetes Care 28 (2005) 2673–2679.
10. Mollema ED, Snoek FJ, Pouwer F, Heine RJ, van der Ploeg HM. Diabetes fear of injecting and self-testing questionnaire: a psychometric evaluation. Diabetes Care. 2000;23:765–769
    • MEDLINE
    • CrossRef
11. Veltmaat LJ, Miedema K, Reenders K. Overschakeling op insuline bij NIADM-patiënten. (Conversion to insulin in not insulin dependent diabetes mellitus patients), in Dutch with English abstract. Huisarts en Wetenschap. 1995;38:608–613
12. Riddle MC. The underuse of insulin therapy in North America. Diabetes Metab. Res. Rev. 2002;18:S42–S49
    • CrossRef
13. Kenens R, Hingstman L. Cijfers uit de registratie van huisartsen. Peiling 2004 (General Practitioners registration. Survey 2004). The Netherlands Institute for Health Services Research (NIVEL); 2004;
14. Jeavons D, Hungin APS, Cornford CS. Patients with poorly controlled diabetes in primary care: healthcare clinicians’ beliefs and attitudes. Postgrad. Med. J. 2006;82:347–350
    • CrossRef
15. Davis SN, Renda SM. Psychological insulin resistance: overcoming barriers to starting insulin therapy. Diabetes Educ. 2006;32:146S–152S
    • CrossRef
16. Goudswaard AN, Stolk RP, Zuithoff P, de Valk HW, Rutten GE. Starting insulin in type 2 diabetes: continue oral hypoglycemic agents? A randomized trial in primary care. J. Fam. Pract. 2004;53:393–399
    • MEDLINE
17. A.N. Goudswaard, F.N.J. Furlong, G.D. Valk, R.P. Stolk, G.E. Rutten, Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus, Cochrane Collaboration, Metabolic and Endocrine Disorders Group 2004, 2004.
18. Haque M, Hayden Emerson S, Dennison CR, Navsa M, Levitt NS. Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town. SAMJ. 2005;95:798–802
19. Goudswaard AN, Stolk RP, Zuithoff NPA, de Valk HW, Rutten GEHM. Long-term effects of self-management education for patients with Type 2 diabetes taking maximal oral hypoglycaemic therapy: a randomized trial in primary care. Diabetic Med. 2004;21:491–496
20. Berghout L, Gorter KJ, Rutten GE. Improvement of glycemic regulation without exogenous insulin in 40% of poorly regulated patients with type 2 diabetes mellitus; a study in 18 family practices. Ned Tijdschr Geneeskd. 2001;145:2035–2039
    • MEDLINE
21. Spoelstra JA, Stol RP, de Bruyne MC, Erkens JA, Herings RM, Leufkens HG, et al. Factors associated with switching from oral hypoglycaemic agents to insulin therapy. Neth. J. Med. 2002;60:243–248
    • MEDLINE
22. Mazzaglia G, Yurgin N, Boye KS, Trifirò G, Cottrell S, Allen E, et al. Prevalence and antihyperglycemic prescribing trends for patients with type 2 diabetes in Italy: a 4-year retrospective study from national primary care data. Pharmacol. Res. 2008;57:358–363
    • CrossRef
23. Yurgin N, Secnik K, Lage MJ. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study. Clin. Ther. 2007;29:316–325
    • Abstract
    • Full-Text PDF (661 KB)
    • CrossRef
24. B. Eliasson, K. Eeg-Olofsson, J. Cederholm, P. Nilsson, S. Gudbjornsdottir, Steering Committee of the Swedisch National Diabetes Register (NDR), Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register. Diabetes Metab. 33 (2007) 269–276.
25. de Sonnaville JJ, Snoek FJ, Colly LP, Deville W, Wijkel D, Heine RJ. Well-being and symptoms in relation to insulin therapy in type 2 diabetes. Diabetes Care. 1998;21:919–924
    • MEDLINE
    • CrossRef
26. de Grauw WJ, van de Lisdonk EH, van Gerwen WH, van den Hoogen HJ, van Weel C. Insulin therapy in poorly controlled type 2 diabetic patients: does it affect quality of life?. Br. J. Gen. Pract. 2001;51:527–532
    • MEDLINE
27. Tahrani A, McCarthy M, Godson J, Taylor S, Slater H, Capps N, et al. Diabetes care and the GMS contract: the evidence for a whole county. Br. J. Gen. Pract. 2007;57:483–485
    • MEDLINE
28. Campbell S, Reeves D, Kontopantelis E, Middleton E, Sibbald B, Roland M. Quality of primary care in England with the introduction of pay for performance. N. Engl. J. Med. 2007;357:181–190
    • CrossRef